Royal Prince Alfred Hospital

Sydney, New South Wales 2050

5 studies enrolling now · 24 studies all time

What they study most

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC, Acute Ischemic Stroke Patients Receiving Reperfusion Therapy, Adult B Cell ALL, Autoimmune Pulmonary Alveolar Proteinosis, B-cell Lymphoma, B-cell Malignancy, Brain and Central Nervous System Tumors, Cardiac Surgery, Chronic Graft-versus-host-disease, Chronic Hepatitis, Community-acquired Pneumonia, Influenza, COVID-19, Critical Illness

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• End-Tidal Oxygen for Intubation in the Emergency Department — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD — Running, not enrolling
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) — Stopped early
• Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Completed
• BPL-003 Efficacy and Safety in Treatment Resistant Depression — Completed
• Optimal Post Tpa-Iv Monitoring in Ischemic Stroke — Completed
• A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma — Stopped early
• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations — Completed
• Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) — Running, not enrolling
• Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis — Completed
• Prospective Randomized On-X Versus SJM Evaluation Trial — Completed
• The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? — Completed
• BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients — Withdrawn before enrolling
• The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial — Completed
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus — Stopped early
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus — Stopped early